Navigation Links
Hospira Reports First-Quarter 2012 Results
Date:5/1/2012

/p>

31.1%39.8%37.0%42.3%Income From Operations

4.8%16.3%10.8%20.3%Net Income4.2%15.0%8.1%15.7%Income Tax Rate

(17.3)%6.9%19.0%23.0%(1)

Adjusted financial measures exclude certain specified items as described and reconciled to comparable GAAP financial measures in the Reconciliation of GAAP to Non-GAAP Financial Measures contained in this press release.(2)

Gross profit is defined as Net sales less Cost of products sold. Adjusted gross profit excludes certain specified items, as indicated in the previous footnote.Hospira, Inc.Reconciliation of GAAP to Non-GAAP Financial Measures(Unaudited)(dollars in millions, except for per share amounts)Three months ended March 31, 2012 Reconciliation of GAAP to Non-GAAP Financial Measures:Gross Profit (1)Income From

OperationsNet Income (2)Diluted EPSGAAP financial measures$
300.0$
46.7$
40.2$
.24Specified items:   Amortization of certain intangible assets (A)18.718.713.00.08   Certain quality and product related charges (B)36.936.923.90.14   Capacity expansion related charges (C)1.91.91.30.01Adjusted financial measures (3)$
357.5$
4.2$
78.4$
.47GAAP results for the three months ended March 31, 2012 include:(A)

Amortization of certain intangible assets reported in Cost of products sold resulting from acquisitions including Mayne Pharma Limited ("Mayne Pharma"), Javelin Pharmaceuticals, Inc. ("Javelin Pharma") and a generic injectable business by Hospira Healthcare India Private Limited ("Hospira India").(B)

Certain quality and product related charges reported in Cost of products sold primarily include third party oversight and consulting costs, reduced production volume related costs and penalties for failure to supp
'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
2. Hospira Joins the Generic Pharmaceutical Association
3. Hospira Works With FDA to Help Avert Methotrexate Shortage; Shipping One Months Supply of New Product Immediately and on Track to Ensure Sustainable Supply
4. Hospira Announces Start of U.S. Phase III Biosimilar EPO Clinical Program
5. Hospira to Host Conference Call for Fourth-Quarter 2011 Results and 2012 Projections
6. Hospira to Present at the J.P. Morgan 30th Annual Healthcare Conference Jan. 10, 2012
7. Hospira Reports Third-Quarter 2011 Results
8. Hospira Announces Certain Preliminary Third-Quarter 2011 Results
9. Hospira to Host Conference Call for Third-Quarter 2011 Results
10. Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
11. Hospira to Host 2011 Investor Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... May 4, 2015  Neurocrine Biosciences, Inc. (NASDAQ: ... has joined the company as Vice President, Medical ... welcome Dr. Bill Aurora to the Neurocrine ... Kevin Gorman , President and Chief Executive Officer of ... exchange and outreach coupled with his extensive network and ...
(Date:5/4/2015)... May 4, 2015  Amgen (NASDAQ: AMGN ) will ... 8 a.m. ET on Thursday, May 7, 2015, at the ... Hooper , executive vice president of Global Commercial Operations at ... presentation can be accessed from the Events Calendar on Amgen,s ... webcast will also be available on Amgen,s website for 90 ...
(Date:5/4/2015)... , May 4, 2015 DePuy Synthes CMF* ... Repair, the first commercially available biosynthesized dural replacement derived ... is a part of the DePuy Synthes Companies of ... tissue membrane that covers and protects the brain and ... to allow surgeons to access the brain. A dural ...
Breaking Medicine Technology:Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 2Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 3Amgen To Present At The Deutsche Bank 40th Annual Healthcare Conference 2DePuy Synthes CMF Launches First Biosynthesized Cellulose-Based Dural Replacement For Neurosurgery 2DePuy Synthes CMF Launches First Biosynthesized Cellulose-Based Dural Replacement For Neurosurgery 3
... YORK, Jan. 10, 2011 Resolvyx Pharmaceuticals ( Resolvyx ... ), a successor firm to Celtic Pharma, announced today ... which Celtic Therapeutics has acquired and licensed worldwide rights ... treatment of dry eye syndrome and other ophthalmic conditions. ...
... 2011 Astellas Pharma Inc. (TSE: 4503) ... to conduct, in conjunction with executive management, a review of ... Prosidion was acquired as part of Astellas, acquisition of OSI ... two drug candidates in development for diabetes and obesity, as ...
Cached Medicine Technology:Resolvyx Pharmaceuticals and Celtic Therapeutics Enter Final Agreement in Ophthalmology 2Resolvyx Pharmaceuticals and Celtic Therapeutics Enter Final Agreement in Ophthalmology 3Resolvyx Pharmaceuticals and Celtic Therapeutics Enter Final Agreement in Ophthalmology 4Astellas to Review Strategic Business Alternatives for Prosidion Subsidiary 2Astellas to Review Strategic Business Alternatives for Prosidion Subsidiary 3
(Date:5/4/2015)... NY (PRWEB) May 04, 2015 ... insurance programs, announces the expansion of coverage for its ... a leading provider of industry-tailored insurance and proactive risk ... & Company, we are dedicated to providing our customers ... meet their many evolving needs. We are excited to ...
(Date:5/4/2015)... TROY Healthcare Solutions is proud to be a ... (RUG) Conference in Baltimore, MD from May 11 – ... provides an opportunity for clients to gather to network, ... In addition to sponsoring the event, TROY Healthcare Solutions ... Conference. Attendees can stop by the TROY booth and ...
(Date:5/4/2015)... May 04, 2015 Baptist Medical ... Stroke Association’s Get With The Guidelines®-Stroke Gold Plus ... Honor Roll. The award recognizes the hospital’s commitment ... the most appropriate treatment according to nationally recognized, ... , To receive the Gold Plus Quality Achievement ...
(Date:5/4/2015)... May 04, 2015 Now in its ... clinical leaders who have made outstanding contributions to the ... serve, both in acute and post-acute care settings. The ... Post-Acute Provider of the Year, Advanced Practice Clinician of ... Provider of the Year. Recipients are selected by IPC’s ...
(Date:5/4/2015)... May 04, 2015 Los Angeles ... offering a more comfortable and attractive alternative for patients ... choice for those who have lost teeth. Unfortunately, they ... insecure or slip at the worst possible moment and ... talks. They can also painfully pinch or rub gums, ...
Breaking Medicine News(10 mins):Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 2Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 3Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 3Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 2Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 3Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 4Health News:IPC Healthcare Announces Clinicians of the Year 2Health News:IPC Healthcare Announces Clinicians of the Year 3Health News:Los Angeles Dental Implants Doctor, Kevin Sands DDS, Now Offers a More Comfortable and Aesthetically-Pleasing Solution to Denture-Wearers 2
... , , WAYNE, Pa., July ... documentation software, workflow tools, consulting and staffing services has announced ... Marketing and Communications. Reporting directly to founder and CEO ... marketing initiatives that blend the strong brand of Precyse,s services ...
... , BATESVILLE, Ind., July 29 Hillenbrand, Inc. (NYSE: ... the market opens Wednesday, Aug. 12, 2009. The full text of ... site at www.HillenbrandInc.com . , , ... with investors and financial analysts the same day at 8 a.m. ...
... , CARLSBAD, Calif., July ... announced today that Cardiac Science Corporation has purchased a ... Group. Cardiac Science develops, manufactures, and markets ... and Holter systems, cardiac rehabilitation telemetry, and data management ...
... , , DARIEN, Conn., July 29 ... The Switch , a sparkling 100% juice, is expanding its availability ... Amazon.com, The Switch has added key retailers Tops, ... months. And the list of eager retailers keeps growing with Wegmans, ...
... , , CARMEL, Ind., ... announced that Christopher J. Foote has been promoted to vice president, ... in 1999 and served previously as senior managing actuary for asset-liability ... and shared actuarial services. , , ...
... , SAN DIEGO, July 29 ... solutions that can reach over 3.5 billion mobile phones globally, today announced ... industry leaders. , , Key Facts: , ... the 7-member advisory board is to provide Globaltel Media,s executive management team ...
Cached Medicine News:Health News:Precyse Solutions Taps Former Siemens Executive to Lead New Marketing Organization 2Health News:Hillenbrand Announces Third-Quarter Earnings Release Date and Conference Call 2Health News:Patriot Scientific Corporation Announces Cardiac Science Corporation's Purchase of a Moore Microprocessor Patent(TM) Portfolio License 2Health News:People Across the Country are Making The Switch! 2Health News:Globaltel Media Appoints Leading Healthcare Industry Veterans to Advisory Board 2Health News:Globaltel Media Appoints Leading Healthcare Industry Veterans to Advisory Board 3
The DePuy ACE 8.0mm Cannulated Cancellous Screw incorporates TiMAX to provide superior strength, fatigue resistance and a lower modulus of elasticity when compared to similar stainless steel devices....
Biomet® Arthrodesis Nail indications include: , Failed external fixation , Aseptic failed total knee arthroplasty , Periarticular fractures where repair is not possible , Limb salvage in tumor...
True hemostasis management is achieved with the Hepcon HMS PLUS Hemostasis Management System from Medtronic. This multi-purpose, intuitive system easily performs in-vitro diagnostic procedures....
An Innovative New System to Help You Meet the Challenges of Anterior Spine Surgery...
Medicine Products: